EBI3 antibody (AA 107-156)
Quick Overview for EBI3 antibody (AA 107-156) (ABIN6744719)
Target
See all EBI3 (IL-27b) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 107-156
-
Specificity
- Human EBI3
-
Predicted Reactivity
- Percent identity by BLAST analysis:
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa107-156 of human EBI3 (Q14213, NP_005746). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla (100%), Guinea pig (92%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))
-
Alternative Name
- EBI3
-
Background
-
Name/Gene ID: EBI3
Synonyms: EBI3, Epstein-Barr virus induced 3, IL-27 subunit beta, IL27 subunit, IL27B, Interleukin-27 subunit beta, IL-27B, Cytokine receptor, EBV-induced gene 3 protein, IL35 subunit -
Gene ID
- 10148
-
NCBI Accession
- NP_005746
-
UniProt
- Q14213
Target
-